Education Session
206 - Process Analytical Technology (PAT) Used
for PQLI® and QbD: Implementation Update,
Examples, and Discussion
9 November 13.30-17.00
ISPE CEUs: 0.25
Tracks: ProductRegulatoryQuality
There is a stated need by industry for concrete PAT/ QbD examples. PQLI and PAT concepts are well defined; however, there are still more questions than answers on how to successfully implement and why the industry would want to devote resources to these concepts. The groundwork has been laid, and now the time has come to determine how to successfully use the experience of others. The intent is not to stand up and teach the right answer, but to lead a discussion for discovery. This session will address the following topics:
- Description and discussion of the four PAT tools
- Benefits and value of PAT
- Examples showing the combination of the PAT tools in one system, with a description of realized benefits
- Question and answer session
This session content is rated advanced as attendees should understand the definitions, current guidance, and theory behind PAT, QbD, and PQLI.
How you will Benefit
At the end of this session, participants will be able to:
- Understand how to communicate the concepts to stakeholders
- Research and develop process data gathering projects using PAT/PQLI
- Determine a path forward for utilization of process data for process improvement
- Understand and determine the application of process improvement tools and methods in a validated environment
Who Should Attend
Professionals from process development, validation, quality, manufacturing, automation, and engineering
ISPE Communities of Practice (COPs)
Biotech, C®Q, GAMP, OSD, PAT, PPD, and PM
View the ISPE Community of Practice (COP) Guide
Session Leader
- Nathan Temple, Project Manager, Commissioning Agents Inc USA
Session Presenters
- Nicolas Abatzoglou, PhD, Eng., Professor, University of Sherbrooke Canada
- Duncan Low, PhD, Scientific Executive Director, Amgen Inc USA
- Jean-Sebastien Simard, Senior PAT Scientist, Pfizer Canada Canada
- Stephen Tyler, Dir Strategic Quality & Tech Ops, Abbott Laboratories USA
